By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Array BioPharma, Inc. 

3200 Walnut Street

Boulder  Colorado  80301  U.S.A.
Phone: 303-381-6600 Fax: 303-381-6697


Drug Discovery

Company News
Pierre Fabre And Array BioPharma (ARRY) Release: COLUMBUS Phase 3 Study Results In BRAF-Mutant Melanoma Presented At Society For Melanoma Research Annual Congress 11/9/2016 10:27:43 AM
Array BioPharma (ARRY) Reports Financial Results For The First Quarter Of Fiscal 2017 11/1/2016 9:53:56 AM
Array BioPharma (ARRY) To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016 10/25/2016 10:12:52 AM
Array BioPharma (ARRY) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares 10/3/2016 9:48:56 AM
Array BioPharma (ARRY) Announces Proposed Public Offering Of Common Stock 9/28/2016 6:51:29 AM
Array BioPharma (ARRY) Rockets as Melanoma Drug Meets Endpoint in Phase III Study 9/26/2016 7:06:31 AM
Array BioPharma (ARRY) Announces Phase 3 BEACON CRC SPA Agreement With FDA 9/14/2016 6:28:57 AM
Array BioPharma (ARRY) To Present At The Morgan Stanley Global Healthcare Conference 9/6/2016 2:01:04 PM
5 Biotechs Under $10 With Massive Potential 9/6/2016 6:19:02 AM
Array BioPharma (ARRY) Announces FDA Acceptance Of Binimetinib NDA For Patients With Advanced NRAS-Mutant Melanoma 9/1/2016 8:20:58 AM